Paclitaxel and Pazopanib in Ovarian Cancer-Reply

JAMA Oncol. 2018 Sep 1;4(9):1299. doi: 10.1001/jamaoncol.2018.1712.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Humans
  • Indazoles
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms*
  • Paclitaxel*
  • Pyrimidines
  • Sulfonamides

Substances

  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib
  • Paclitaxel